Boris Pasche - Publications

Affiliations: 
Integrated Graduate Program in the Life Sciences Northwestern University, Evanston, IL 
Area:
Genetics, Cell Biology

16/90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, ... ... Pasche B, et al. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1326-38. PMID 25190698  0.48
2011 Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, Xu Y, Tofilon S, Agarwal S, Pasche B, Mantzoros C. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. Bmc Medical Genetics. 12: 52. PMID 21489227 DOI: 10.1186/1471-2350-12-52  0.48
2011 Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism: Clinical and Experimental. 60: 1234-43. PMID 21397927 DOI: 10.1016/j.metabol.2011.01.005  0.48
2010 Pasche B, Wisinski KB, Sadim M, Kaklamani V, Pennison MJ, Zeng Q, Bellam N, Zimmerman J, Yi N, Zhang K, Baron J, Stram DO, Hayes MG. Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs. Journal of Experimental & Clinical Cancer Research : Cr. 29: 57. PMID 20500843 DOI: 10.1186/1756-9966-29-57  0.48
2010 Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, Garber JE, Goorha S, Gruber SB, Hampel H, Kaklamani V, Kohlmann W, Kurian A, Litton J, Marcom PK, ... ... Pasche B, et al. Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network : Jnccn. 8: 562-94. PMID 20495085  0.48
2009 Zeng Q, Phukan S, Xu Y, Sadim M, Rosman DS, Pennison M, Liao J, Yang GY, Huang CC, Valle L, Di Cristofano A, de la Chapelle A, Pasche B. Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. Cancer Research. 69: 678-86. PMID 19147584 DOI: 10.1158/0008-5472.CAN-08-3980  0.48
2009 Rebbeck TR, Antoniou AC, Llopis TC, Nevanlinna H, Aittomäki K, Simard J, Spurdle AB, Couch FJ, Pereira LH, Greene MH, Andrulis IL, Pasche B, Kaklamani V, et al. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Research and Treatment. 115: 185-92. PMID 18523885 DOI: 10.1007/s10549-008-0064-8  0.48
2008 Rosman DS, Phukan S, Huang CC, Pasche B. TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation. Cancer Research. 68: 1319-28. PMID 18316594 DOI: 10.1158/0008-5472.CAN-07-5424  0.48
2007 Bian Y, Knobloch TJ, Sadim M, Kaklamani V, Raji A, Yang GY, Weghorst CM, Pasche B. Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development. Human Molecular Genetics. 16: 3128-35. PMID 17890272 DOI: 10.1093/hmg/ddm274  0.48
2007 Rosman DS, Kaklamani V, Pasche B. New insights into breast cancer genetics and impact on patient management. Current Treatment Options in Oncology. 8: 61-73. PMID 17634833 DOI: 10.1007/s11864-007-0021-5  0.48
2005 Kaklamani V, Pasche B. Transforming Growth Factor Beta and breast cancer. Cancer Treatment and Research. 126: 129-56. PMID 16209065  0.48
2005 Pasche B, Knobloch TJ, Bian Y, Liu J, Phukan S, Rosman D, Kaklamani V, Baddi L, Siddiqui FS, Frankel W, Prior TW, Schuller DE, Agrawal A, Lang J, Dolan ME, et al. Somatic acquisition and signaling of TGFBR1*6A in cancer. Jama. 294: 1634-46. PMID 16204663 DOI: 10.1001/jama.294.13.1634  0.48
2005 Bian Y, Caldes T, Wijnen J, Franken P, Vasen H, Kaklamani V, Nafa K, Peterlongo P, Ellis N, Baron JA, Burn J, Moeslein G, Morrison PJ, Chen Y, Ahsan H, ... ... Pasche B, et al. TGFBR1*6A may contribute to hereditary colorectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3074-8. PMID 15860866 DOI: 10.1200/JCO.2005.00.281  0.48
2004 Kaklamani V, Baddi L, Rosman D, Liu J, Ellis N, Oddoux C, Ostrer H, Chen Y, Ahsan H, Offit K, Pasche B. No major association between TGFBR1*6A and prostate cancer. Bmc Genetics. 5: 28. PMID 15385056 DOI: 10.1186/1471-2156-5-28  0.48
2004 Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, Peterlongo P, Ellis N, Offit K, Caldes T, Reiss M, Zheng T. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 756-8. PMID 14966109 DOI: 10.1200/JCO.2004.99.271  0.48
2003 Bian Y, Kaklamani V, Reich J, Pasche B. TGF-beta signaling alterations in cancer. Cancer Treatment and Research. 115: 73-94. PMID 12613193  0.48
Low-probability matches
2014 Pasche B, Wang M, Pennison M, Jimenez H. Prevention and treatment of cancer with aspirin: where do we stand? Seminars in Oncology. 41: 397-401. PMID 25023355 DOI: 10.1053/j.seminoncol.2014.04.012  0.24
2014 Pasche B, Grant SC. Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design. Jama. 311: 1975-6. PMID 24846033 DOI: 10.1001/jama.2014.3742  0.24
2012 Tuupanen S, Yan J, Turunen M, Gylfe AE, Kaasinen E, Li L, Eng C, Culver DA, Kalady MF, Pennison MJ, Pasche B, Manne U, de la Chapelle A, Hampel H, Henderson BE, et al. Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583. Cancer Genetics. 205: 25-33. PMID 22429595 DOI: 10.1016/j.cancergen.2012.01.005  0.24
2009 Adrian K, Strouch MJ, Zeng Q, Barron MR, Cheon EC, Honasoge A, Xu Y, Phukan S, Sadim M, Bentrem DJ, Pasche B, Grippo PJ. Tgfbr1 haploinsufficiency inhibits the development of murine mutant Kras-induced pancreatic precancer. Cancer Research. 69: 9169-74. PMID 19951995 DOI: 10.1158/0008-5472.CAN-09-1705  0.24
2009 Varga J, Pasche B. Transforming growth factor beta as a therapeutic target in systemic sclerosis Nature Reviews. Rheumatology. 5: 200-206. PMID 19337284 DOI: 10.1038/nrrheum.2009.26  0.24
2008 Varga J, Pasche B. Antitransforming growth factor-β therapy in fibrosis: Recent progress and implications for systemic sclerosis Current Opinion in Rheumatology. 20: 720-728. PMID 18946334 DOI: 10.1097/BOR.0b013e32830e48e8  0.24
2007 DeAngelis CD, Fontanarosa PB, King MC, Pasche B. Genetics and genomics: a call for papers. Archives of Surgery (Chicago, Ill. : 1960). 142: 822. PMID 17875835 DOI: 10.1001/archsurg.142.9.822  0.24
2006 Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton S, Kohlmann W, Ludwig KA, Lynch PM, Marino C, Martin EW, Mayer RJ, ... Pasche B, et al. Colorectal Cancer Screening Clinical Practice Guidelines. Journal of the National Comprehensive Cancer Network : Jnccn. 4: 384-420. PMID 16569391  0.24
2005 Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, ... ... Pasche B, et al. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Cancer Research. 65: 3454-61. PMID 15833881 DOI: 10.1158/0008-5472.CAN-04-2961  0.24
2004 Pasche B, Serhan CN. Is C-reactive protein an inflammation opsonin that signals colon cancer risk? Jama. 291: 623-4. PMID 14762043 DOI: 10.1001/jama.291.5.623  0.24
2008 Valle L, Serena-Acedo T, Liyanarachchi S, Hampel H, Comeras I, Li Z, Zeng Q, Zhang HT, Pennison MJ, Sadim M, Pasche B, Tanner SM, de la Chapelle A. Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science (New York, N.Y.). 321: 1361-5. PMID 18703712 DOI: 10.1126/science.1159397  0.04
2019 Soike MH, Logue J, Qasem S, Hughes RT, McTyre E, Su J, Triozzi P, Bendandi M, Lo HW, Ahmed T, O'Neill SS, Debinski W, Pasche B, Watabe K, Miller LD, et al. CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery. Scientific Reports. 9: 14385. PMID 31591443 DOI: 10.1038/s41598-019-50298-7  0.01
2019 McTyre ER, Soike MH, Farris M, Ayala-Peacock DN, Hepel JT, Page BR, Shen C, Kleinberg L, Contessa JN, Corso C, Chiang V, Henson-Masters A, Cramer CK, Ruiz J, Pasche B, et al. Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 31526671 DOI: 10.1016/j.radonc.2019.08.011  0.01
2019 Sirkisoon SR, Carpenter RL, Rimkus T, Doheny D, Zhu D, Aguayo NR, Xing F, Chan M, Ruiz J, Metheny-Barlow LJ, Strowd R, Lin J, Regua AT, Arrigo A, Anguelov M, ... Pasche B, et al. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment. Oncogene. PMID 31462709 DOI: 10.1038/s41388-019-0959-3  0.01
2019 Bekaii-Saab TS, Ou FS, Ahn DH, Boland PM, Ciombor KK, Heying EN, Dockter TJ, Jacobs NL, Pasche BC, Cleary JM, Meyers JP, Desnoyers RJ, McCune JS, Pedersen K, Barzi A, et al. Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study. The Lancet. Oncology. PMID 31262657 DOI: 10.1016/S1470-2045(19)30272-4  0.01
2019 Jimenez H, Wang M, Zimmerman JW, Pennison MJ, Sharma S, Surratt T, Xu ZX, Brezovich I, Absher D, Myers RM, DeYoung B, Caudell DL, Chen D, Lo HW, Lin HK, ... ... Pasche BC, et al. Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Ca3.2 T-type voltage-gated calcium channels and Ca influx. Ebiomedicine. PMID 31160272 DOI: 10.1016/j.ebiom.2019.05.034  0.01
2019 Sharma S, Wu SY, Jimenez H, Xing F, Zhu D, Liu Y, Wu K, Tyagi A, Zhao D, Lo HW, Metheny-Barlow L, Sun P, Bourland JD, Chan MD, Thomas A, ... ... Pasche B, et al. Ca and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF. Ebiomedicine. PMID 31129098 DOI: 10.1016/j.ebiom.2019.05.038  0.01
2019 Song Q, Hawkins GA, Wudel L, Chou PC, Forbes E, Pullikuth AK, Liu L, Jin G, Craddock L, Topaloglu U, Kucera G, O'Neill S, Levine EA, Sun P, Watabe K, ... ... Pasche B, et al. Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq. Cancer Medicine. PMID 31033233 DOI: 10.1002/cam4.2113  0.01
2019 Guan M, Cho S, Petro R, Zhang W, Pasche B, Topaloglu U. Natural language processing and recurrent network models for identifying genomic mutation-associated cancer treatment change from patient progress notes. Jamia Open. 2: 139-149. PMID 30944913 DOI: 10.1093/jamiaopen/ooy061  0.01
2019 Dohm A, Su J, McTyre ER, Taylor JM, Miller LD, Petty WJ, Xing F, Lo HW, Metheny-Barlow LJ, O'Neill S, Bellinger C, Dotson T, Pasche B, Watabe K, Chan MD, et al. Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial. The International Journal of Biological Markers. 1724600818803104. PMID 30854931 DOI: 10.1177/1724600818803104  0.01
2019 Enomoto LM, Fenstermaker J, Desnoyers RJ, Pasche BC, Blackstock AW, Howerton RM, Clark CJ, Levine EA, Shen P. Oncology Navigation Decreases Time to Treatment in Patients with Pancreatic Malignancy. Annals of Surgical Oncology. PMID 30652224 DOI: 10.1245/s10434-019-07157-6  0.01
2018 Li X, Zhang S, Zhang Q, Wei X, Pan Y, Zhao J, Xin X, Qin C, Wang X, Li J, Yang F, Zhao Y, Yang M, Wang Q, Zheng Z, ... ... Pasche BC, et al. Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study. The Lancet. Oncology. PMID 30583848 DOI: 10.1016/S1470-2045(18)30762-9  0.01
2018 Shenker RF, Hughes RT, McTyre ER, Lanier C, Lo HW, Metheny-Barlow L, Su J, Thomas A, Brown DR, Avery T, Pasche B, Cramer CK, Laxton AW, Tatter SB, Watabe K, et al. Potential prognostic markers for survival and neurologic death in patients with breast cancer brain metastases who receive upfront SRS alone. Journal of Radiosurgery and Sbrt. 5: 277-283. PMID 30538888  0.01
2018 Li X, Pasche B, Zhang W, Chen K. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer. Jama Oncology. PMID 30098163 DOI: 10.1001/jamaoncol.2018.2805  0.01
2018 Xing F, Liu Y, Wu SY, Wu K, Sharma S, Mo YY, Feng J, Sanders S, Jin G, Singh R, Vidi PA, Tyagi A, Chan MD, Ruiz J, Debinski W, ... Pasche BC, et al. Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Research. PMID 30026327 DOI: 10.1158/0008-5472.CAN-18-1102  0.01
2018 Hughes RT, McTyre ER, LeCompte M, Cramer CK, Munley MT, Laxton AW, Tatter SB, Ruiz J, Pasche B, Watabe K, Chan MD. Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain Metastases. Neurosurgery. PMID 29982831 DOI: 10.1093/neuros/nyy276  0.01
2018 Liu L, Ruiz J, O'Neill SS, Grant SC, Petty WJ, Yang M, Chen K, Topaloglu U, Pasche B, Zhang W. Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Molecular Cancer. 17: 81. PMID 29650000 DOI: 10.1186/s12943-018-0832-y  0.01
2018 Rimkus TK, Carpenter RL, Sirkisoon SR, Zhu D, Pasche B, Chan MD, Lesser GJ, Tatter SB, Watabe K, Debinski W, Lo HW. Truncated glioma-associated oncogene homolog 1 (tGLI1) mediates mesenchymal glioblastoma via transcriptional activation of CD44. Cancer Research. PMID 29463580 DOI: 10.1158/0008-5472.CAN-17-2933  0.01
2018 Jin G, Xu C, Zhang X, Long J, Rezaeian AH, Liu C, Furth ME, Kridel S, Pasche B, Bian XW, Lin HK. Atad3a suppresses Pink1-dependent mitophagy to maintain homeostasis of hematopoietic progenitor cells. Nature Immunology. 19: 29-40. PMID 29242539 DOI: 10.1038/s41590-017-0002-1  0.01
2018 Jimenez H, Blackman C, Lesser G, Debinski W, Chan M, Sharma S, Watabe K, Lo HW, Thomas A, Godwin D, Blackstock W, Mudry A, Posey J, O'Connor R, Brezovich I, ... ... Pasche B, et al. Use of non-ionizing electromagnetic fields for the treatment of cancer. Frontiers in Bioscience (Landmark Edition). 23: 284-297. PMID 28930547  0.01
2017 Carpenter RL, Sirkisoon S, Zhu D, Rimkus T, Harrison A, Anderson A, Paw I, Qasem S, Xing F, Liu Y, Chan M, Metheny-Barlow L, Pasche BC, Debinski W, Watabe K, et al. Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Oncotarget. 8: 73947-73963. PMID 29088759 DOI: 10.18632/oncotarget.18166  0.01
2017 Kytola V, Topaloglu U, Miller LD, Bitting RL, Goodman MM, D Agostino RB, Desnoyers RJ, Albright C, Yacoub G, Qasem SA, DeYoung B, Thorsson V, Shmulevich I, Yang M, Shcherban A, ... ... Pasche B, et al. Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center. Theranostics. 7: 2914-2923. PMID 28824725 DOI: 10.7150/thno.20355  0.01
2017 Carpenter RL, Sirkisoon S, Zhu D, Rimkus T, Harrison A, Anderson A, Paw I, Qasem S, Xing F, Liu Y, Chan M, Metheny-Barlow L, Pasche BC, Debinski W, Watabe K, et al. Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Oncotarget. PMID 28598816 DOI: 10.18632/oncotarget.18166  0.01
2017 Alistar A, Morris BB, Desnoyer R, Klepin HD, Hosseinzadeh K, Clark C, Cameron A, Leyendecker J, D'Agostino R, Topaloglu U, Boteju LW, Boteju AR, Shorr R, Zachar Z, Bingham PM, ... ... Pasche B, et al. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. The Lancet. Oncology. PMID 28495639 DOI: 10.1016/S1470-2045(17)30314-5  0.01
2017 Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, ... ... Pasche B, et al. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. Journal of Hematology & Oncology. 10: 100. PMID 28472989 DOI: 10.1186/s13045-017-0468-1  0.01
2016 Pasche B, Pennison MJ, DeYoung B. Lynch Syndrome Testing: A Missed Opportunity in the Era of Precision Medicine. Jama. 316: 38-9. PMID 27380341 DOI: 10.1001/jama.2016.8291  0.01
2016 Xing F, Liu Y, Sharma S, Wu K, Chan MD, Lo HW, Carpenter RL, Metheny-Barlow LJ, Zhou X, Qasem SA, Pasche B, Watabe K. Activation of the c-Met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer. Cancer Research. PMID 27364556 DOI: 10.1158/0008-5472.CAN-15-3541  0.01
2016 Principe DR, DeCant B, Staudacher J, Vitello D, Mangan RJ, Wayne EA, Mascariñas E, Diaz AM, Bauer J, McKinney RD, Khazaie K, Pasche B, Dawson DW, Munshi HG, Grippo PJ, et al. Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation. Oncotarget. PMID 27270652 DOI: 10.18632/oncotarget.9830  0.01
2016 Capstick M, Gong Y, Pasche B, Kuster N. An HF exposure system for mice with improved efficiency. Bioelectromagnetics. 37: 223-33. PMID 27037618 DOI: 10.1002/bem.21969  0.01
2016 Principe DR, DeCant B, Mascarinas E, Wayne E, Diaz A, Akagi N, Hwang RF, Pasche B, Dawson DW, Fang D, Bentrem DJ, Munshi HG, Jung B, Grippo PJ. TGFβ signaling in the pancreatic tumor microenvironment promotes fibrosis and immune evasion to facilitate tumorigenesis. Cancer Research. PMID 26980767 DOI: 10.1158/0008-5472.CAN-15-1293  0.01
2014 Pasche B, Pennison MJ, Jimenez H, Wang M. TGFBR1 and cancer susceptibility. Transactions of the American Clinical and Climatological Association. 125: 300-12. PMID 25125747  0.01
2014 Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ. TGF-β: duality of function between tumor prevention and carcinogenesis. Journal of the National Cancer Institute. 106: djt369. PMID 24511106 DOI: 10.1093/jnci/djt369  0.01
2014 Liu NN, Xi Y, Callaghan MU, Fribley A, Moore-Smith L, Zimmerman JW, Pasche B, Zeng Q, Li YL. SMAD4 is a potential prognostic marker in human breast carcinomas. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 641-50. PMID 23975369 DOI: 10.1007/s13277-013-1088-1  0.01
2013 Zimmerman JW, Jimenez H, Pennison MJ, Brezovich I, Morgan D, Mudry A, Costa FP, Barbault A, Pasche B. Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies. Chinese Journal of Cancer. 32: 573-81. PMID 24206915 DOI: 10.5732/cjc.013.10177  0.01
2013 Pasche B. Differential effects of aspirin before and after diagnosis of colorectal cancer. Jama. 309: 2598-9. PMID 23800937 DOI: 10.1001/jama.2013.6600  0.01
2013 Chen J, Liu RY, Yang L, Zhao J, Zhao X, Lu D, Yi N, Han B, Chen XF, Zhang K, He J, Lei Z, Zhou Y, Pasche B, Li X, et al. A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk. Journal of Cancer Research and Clinical Oncology. 139: 231-42. PMID 23052692 DOI: 10.1007/s00432-012-1314-z  0.01
2012 Borate U, Absher D, Erba HP, Pasche B. Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML. Expert Review of Anticancer Therapy. 12: 1289-97. PMID 23176617 DOI: 10.1586/era.12.116  0.01
2012 Pasche B. Aspirin--from prevention to targeted therapy. The New England Journal of Medicine. 367: 1650-1. PMID 23094728 DOI: 10.1056/NEJMe1210322  0.01
2012 Liu RY, Song X, Chen P, Lei Z, Miao J, Yi N, Zhang K, Pasche B, Zhang HT. Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals. Experimental and Therapeutic Medicine. 3: 655-664. PMID 22969947 DOI: 10.3892/etm.2012.454  0.01
2011 Pasche B, Absher D. Whole-genome sequencing: a step closer to personalized medicine. Jama. 305: 1596-7. PMID 21505140 DOI: 10.1001/jama.2011.484  0.01
2011 Moore-Smith L, Pasche B. TGFBR1 signaling and breast cancer. Journal of Mammary Gland Biology and Neoplasia. 16: 89-95. PMID 21461994 DOI: 10.1007/s10911-011-9216-2  0.01
2011 Yi N, Kaklamani VG, Pasche B. Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk. Annals of Human Genetics. 75: 90-104. PMID 20846215 DOI: 10.1111/j.1469-1809.2010.00605.x  0.01
2010 Pasche B. Cancer genetics. Introduction. Cancer Treatment and Research. 155: xi-xii. PMID 20698080  0.01
2010 Bellam N, Pasche B. Tgf-beta signaling alterations and colon cancer. Cancer Treatment and Research. 155: 85-103. PMID 20517689 DOI: 10.1007/978-1-4419-6033-7_5  0.01
2010 Pasche B, Yi N. Candidate gene association studies: successes and failures. Current Opinion in Genetics & Development. 20: 257-61. PMID 20417090 DOI: 10.1016/j.gde.2010.03.006  0.01
2010 Pasche B, McNutt RA, Fontanarosa PB. Caring for patients with cancer. Jama. 303: 1094-5. PMID 20233832 DOI: 10.1001/jama.2010.285  0.01
2010 Pasche B. The cover. Physichromie no. 965. Jama. 303: 1015. PMID 20233811 DOI: 10.1001/jama.2010.220  0.01
2009 Lei Z, Liu RY, Zhao J, Liu Z, Jiang X, You W, Chen XF, Liu X, Zhang K, Pasche B, Zhang HT. TGFBR1 haplotypes and risk of non-small-cell lung cancer. Cancer Research. 69: 7046-52. PMID 19690145 DOI: 10.1158/0008-5472.CAN-08-4602  0.01
2009 Pasche B, Myers RM. One step forward toward identification of the genetic signature of glioblastomas. Jama. 302: 325-6. PMID 19602695 DOI: 10.1001/jama.2009.1023  0.01
2009 Barbault A, Costa FP, Bottger B, Munden RF, Bomholt F, Kuster N, Pasche B. Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. Journal of Experimental & Clinical Cancer Research : Cr. 28: 51. PMID 19366446 DOI: 10.1186/1756-9966-28-51  0.01
2008 Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B. Role of polymorphisms in Adamantiades-Behçet's disease. The Journal of Rheumatology. 35: 2376-8. PMID 18925687  0.01
2008 Kaklamani VG, Wisinski KB, Sadim M, Gulden C, Do A, Offit K, Baron JA, Ahsan H, Mantzoros C, Pasche B. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. Jama. 300: 1523-31. PMID 18827209 DOI: 10.1001/jama.300.13.1523  0.01
2008 Pasche B. Familial colorectal cancer: a genetics treasure trove for medical discovery. Jama. 299: 2564-5. PMID 18523226 DOI: 10.1001/jama.299.21.2564  0.01
2008 Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, Ahsan H, Pasche B, Mantzoros C. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Research. 68: 3178-84. PMID 18451143 DOI: 10.1158/0008-5472.CAN-08-0533  0.01
2008 Fontanarosa PB, Pasche B, DeAngelis CD. Genetics and genomics for clinicians. Jama. 299: 1364-5. PMID 18349101 DOI: 10.1001/jama.299.11.1364  0.01
2008 Pasche B. Recent advances in breast cancer genetics. Cancer Treatment and Research. 141: 1-10. PMID 18274079  0.01
2007 Pennison M, Pasche B. Targeting transforming growth factor-beta signaling. Current Opinion in Oncology. 19: 579-85. PMID 17906455 DOI: 10.1097/CCO.0b013e3282f0ad0e  0.01
2007 Xu Y, Pasche B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Human Molecular Genetics. 16: R14-20. PMID 17613544 DOI: 10.1093/hmg/ddl486  0.01
2006 Pasche B. A new strategy in the war on renal cell cancer: hitting multiple targets with limited collateral damage. Jama. 295: 2537-8. PMID 16757727 DOI: 10.1001/jama.295.21.2537  0.01
2006 Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, ... ... Pasche B, et al. Genetic/familial high-risk assessment: breast and ovarian. Journal of the National Comprehensive Cancer Network : Jnccn. 4: 156-76. PMID 16451772  0.01
2004 Kaklamani VG, Pasche B. Role of TGF-beta in cancer and the potential for therapy and prevention. Expert Review of Anticancer Therapy. 4: 649-61. PMID 15270668 DOI: 10.1586/14737140.4.4.649  0.01
2004 Patel JD, Pasche B, Argiris A. Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go. Critical Reviews in Oncology/Hematology. 50: 175-86. PMID 15182824 DOI: 10.1016/j.critrevonc.2004.02.004  0.01
2003 Kaklamani VG, Hou N, Bian Y, Reich J, Offit K, Michel LS, Rubinstein WS, Rademaker A, Pasche B. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3236-43. PMID 12947057 DOI: 10.1200/JCO.2003.11.524  0.01
2002 Pasche B, Mulcahy M, Benson AB. Molecular markers in prognosis of colorectal cancer and prediction of response to treatment. Best Practice & Research. Clinical Gastroenterology. 16: 331-45. PMID 11969242 DOI: 10.1053/bega.2002.0289  0.01
Hide low-probability matches.